Literature DB >> 17600221

Discovery of osmosensitive transcriptional regulation of human cytochrome P450 3As by the tonicity-responsive enhancer binding protein (nuclear factor of activated T cells 5).

Kazuhiro Kosuge1, Andrew I Chuang, Satoko Uematsu, Kah Poh Tan, Kyoichi Ohashi, Ben C B Ko, Shinya Ito.   

Abstract

We report the discovery of an osmosensitive transcriptional control of human CYP3A4, CYP3A7, and CYP3A5. Ambient hypertonicity (350-450 mOsmol/kg) increased mRNA expressions of the CYP3A by approximately 10- to 20-fold in human-intestinal C(2)bbe1 cells, followed by an increase of CYP3A protein. Hypotonicity, on the other hand, suppressed CYP3A mRNA levels, indicating that physiological isotonic conditions may regulate the basal expression of CYP3A. Similar responses to ambient tonicity were observed in other human-derived cell lines (intestinal LS180 and hepatic HepG2) and human primary colonic cells. The 11-base pair tonicity-responsive enhancer (TonE) is an osmosensitive regulator that is activated by the transcription factor, the nuclear factor of activated T-cells 5 (NFAT5). Luciferase-based reporter assays of 13 consensus TonE motifs within +/-10 kilobases (kb) from the transcription start sites of CYP3A showed that only the CYP3A7 intron 2 region ( approximately 5 kb downstream from the transcription start site), which contains two TonE motifs (+5076/+5086 and + 5417/+5427), was responsive to hypertonicity stimuli. This observation was confirmed upon cotransfection with an NFAT5 expression vector, small interfering RNA, or dominant-negative NFAT5. Deletion and mutation analyses suggested that the TonE (+5417/+5427) is indispensable for the enhancer activity. NFAT5 binding to the CYP3A7 intron 2 TonE motif was demonstrated with electrophoretic mobility shift assay and in a native cell context by chromatin immunoprecipitation. We conclude that transcription of human CYP3A is influenced by ambient tonicity. The physiological significance of the tonic regulation of CYP3A enzymes remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600221     DOI: 10.1124/mol.107.034504

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  The role of hyperosmotic stress in inflammation and disease.

Authors:  Chad Brocker; David C Thompson; Vasilis Vasiliou
Journal:  Biomol Concepts       Date:  2012-08

Review 2.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

3.  Mechanisms of fenthion activation in rainbow trout (Oncorhynchus mykiss) acclimated to hypersaline environments.

Authors:  Ramon Lavado; John M Rimoldi; Daniel Schlenk
Journal:  Toxicol Appl Pharmacol       Date:  2008-12-09       Impact factor: 4.219

4.  NFAT5-dependent expression of AQP4 in astrocytes.

Authors:  Min-Hee Yi; Young Sook Lee; Joon Won Kang; Soo Jin Kim; Sang-Ha Oh; Yong Min Kim; Young Ho Lee; Sang Do Lee; Dong Woon Kim
Journal:  Cell Mol Neurobiol       Date:  2012-11-20       Impact factor: 5.046

5.  Role of NFAT5 in inflammatory disorders associated with osmotic stress.

Authors:  Wolfgang Neuhofer
Journal:  Curr Genomics       Date:  2010-12       Impact factor: 2.236

6.  Exploring the relationship between lifestyles, diets and genetic adaptations in humans.

Authors:  Cristina Valente; Luis Alvarez; Sarah J Marks; Ana M Lopez-Parra; Walther Parson; Ockie Oosthuizen; Erica Oosthuizen; António Amorim; Cristian Capelli; Eduardo Arroyo-Pardo; Leonor Gusmão; Maria J Prata
Journal:  BMC Genet       Date:  2015-05-28       Impact factor: 2.797

7.  Inducible nucleosome depletion at OREBP-binding-sites by hypertonic stress.

Authors:  Edith H Y Tong; Jin-Jun Guo; Song-Xiao Xu; Keri Mak; Sookja K Chung; Stephen S M Chung; Ali-Long Huang; Ben C B Ko
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

8.  Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.

Authors:  Murielle Bochud; Michel Burnier; Idris Guessous
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-12

9.  NFAT5 in cellular adaptation to hypertonic stress - regulations and functional significance.

Authors:  Chris Yk Cheung; Ben Cb Ko
Journal:  J Mol Signal       Date:  2013-04-23

10.  The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan.

Authors:  Namyi Gu; Joo-Youn Cho; Kwang-Hee Shin; In-Jin Jang; Moo-Yong Rhee
Journal:  Drug Des Devel Ther       Date:  2016-04-19       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.